Envoy Medical Files 8-K with Financials
Ticker: COCHW · Form: 8-K · Filed: Sep 19, 2025 · CIK: 1840877
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-structure
TL;DR
Envoy Medical filed an 8-K on 9/19/25, updating on financials and corporate structure.
AI Summary
Envoy Medical, Inc. filed an 8-K on September 19, 2025, reporting on other events and financial statements. The company, formerly Anzu Special Acquisition Corp I, is incorporated in Delaware and operates in the orthopedic, prosthetic & surgical appliances & supplies industry. The filing includes details on its common stock and redeemable warrants.
Why It Matters
This filing provides an update on Envoy Medical's corporate and financial status, which is important for investors to understand the company's current reporting and structure.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant events or financial updates, and does not inherently indicate high risk.
Key Numbers
- 001-40133 — SEC File Number (Identifies the company's filing with the SEC)
- 86-1369123 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Envoy Medical, Inc. (company) — Registrant
- Anzu Special Acquisition Corp I (company) — Former Company Name
- September 19, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 3842 (sic_code) — Standard Industrial Classification
FAQ
What is the primary business of Envoy Medical, Inc.?
Envoy Medical, Inc. operates in the orthopedic, prosthetic & surgical appliances & supplies industry, with SIC code 3842.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 19, 2025.
What was Envoy Medical, Inc. formerly known as?
Envoy Medical, Inc. was formerly known as Anzu Special Acquisition Corp I.
In which state is Envoy Medical, Inc. incorporated?
Envoy Medical, Inc. is incorporated in Delaware.
What is the address of Envoy Medical's principal executive office?
The address of Envoy Medical's principal executive office is 4875 White Bear Parkway, White Bear Lake, MN 55110.
Filing Stats: 466 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-09-19 06:23:37
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share COCH The Nasdaq Stock Mar
- $11.50 — A Common Stock at an exercise price of $11.50 per share COCHW The Nasdaq Stock Ma
Filing Documents
- ea0257953-8k_envoy.htm (8-K) — 30KB
- ea025795301ex99-1_envoy.htm (EX-99.1) — 17KB
- 0001213900-25-089225.txt ( ) — 258KB
- coch-20250919.xsd (EX-101.SCH) — 4KB
- coch-20250919_def.xml (EX-101.DEF) — 26KB
- coch-20250919_lab.xml (EX-101.LAB) — 36KB
- coch-20250919_pre.xml (EX-101.PRE) — 25KB
- ea0257953-8k_envoy_htm.xml (XML) — 6KB
01 Other Events
Item 8.01 Other Events On September 19, 2025, Envoy Medical, Inc. (the "Company") issued a press release announcing the Company's receipt of a European patent titled "Implantable Cochlear System with Integrated Components and Lead Characterization." A copy of the press release is attached hereto and incorporated by reference herein as Exhibit 99.1. Item9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Envoy Medical, Inc. Press Release, dated September 19, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENVOY MEDICAL, INC. September 19, 2025 By: /s/ Brent T. Lucas Brent T. Lucas Chief Executive Officer 2